2020 Medicinal Chemistry Reviews
Case History: Eucrisa® (Crisaborole Ointment, 2%), A Boron-Based PDE4 Inhibitor for the Topical Treatment of Atopic Dermatitis
Matthew A. Perry
Ref. n°: REV2020-ch25
You must be connected to be able to download the pdf file of this chapter.